Description of the Sample of HIV-Positive Women Presenting for Colposcopy
| Variable | N | Percent | No Dysplasia (N = 116) N (%) | Mild Dysplasia(N = 41) N (%) | Severe Dysplasia (N = 43) N (%) | P Value* |
|---|---|---|---|---|---|---|
| CD4 count ≥ 200 μL | 128 | 64.3 | 85 (73.3) | 21 (51.2) | 22 (52.4) | .008 |
| HIV viral load ≥10,000 copies/mL | 85 | 43.2 | 45 (38.8) | 22 (55.0) | 18 (43.9) | .20 |
| Ever nondetectable | 87 | 46.8 | 56 (52.8) | 15 (38.5) | 16 (39.0) | .16 |
| HAART therapy >3 months. | 121 | 61.1 | 75 (65.8) | 19 (46.3) | 27 (62.8) | .09 |
| Immune response to HAART* | 96 | 48.0 | 59 (50.9) | 15 (36.6) | 22 (51.2) | .26 |
| HPV high risk positive (N = 160) | 125 | 78.1 | 60 (66.7) | 31 (88.6) | 34 (97.1) | .0003 |
| Mean ± SD(Range) | Mean ± SD | |||||
|---|---|---|---|---|---|---|
| Age | 200 | 36.4 ± 7.3 years (16 to 70) | 37.4 ± 7.5 | 35.0 ± 6.9 | 35.0 ± 6.9 | .07 |
| CD4 count | 199 | 289 ± 223 μL(0 to 1283) | 341 ± 237 | 213 ± 198 | 221 ± 164 | .0005 |
| CD4 Nadir | 196 | 187 ± 176 μL(0 to 1007) | 228 ± 185 | 139 ± 155 | 125 ± 139 | .0006 |
| HIV viral load (log10) | 197 | 3.79 ± 1.09(1.8 to 5.9) | 3.64 ± 1.03 | 4.04 ± 1.23 | 3.96 ± 1.07 | .07 |
| Peak viral load (log10) | 192 | 4.61 ± 0.93(2.6 to 5.9) | 4.51 ± 0.98 | 4.85 ± 0.82 | 4.67 ± 0.85 | .12 |
χ2 comparing 3 groups for percentages; one-way analysis of variance comparing means, 3 groups.
* Defined as >100-μL increase CD4 and/or >1.5 log drop in HIV viral load.